
|Podcasts|September 26, 2022
Pharmacy Focus: Oncology Edition - Experts See Promising Future for the Treatment of Acute Lymphoblastic Leukemia
CAR T therapies are potentially revolutionizing the treatment of acute lymphoblastic leukemia (ALL).
Advertisement
This month, we spoke with Craig Freyer, PharmD, BCOP, clinical pharmacy specialist at Penn Medicine, to learn about how CAR T therapies are potentially revolutionizing the treatment of acute lymphoblastic leukemia (ALL). In addition to discussing what makes ALL treatment unique from other cancer treatments, Freyer said pharmacists have important roles to play in managing cytokine release syndrome and potential neuro-toxicities.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Rocatinlimab Demonstrates Significant Efficacy and Safety in Phase 3 Trials for Moderate-to-Severe Atopic Dermatitis
2
Emerging Therapeutic Strategies Transforming Myelofibrosis Care in 2026
3
Circulating Extracellular Vesicles Contribute to Heart Failure Pathogenesis in CKD
4
Study: Text Reminders Increase Prescription Fulfillment Rates in Patients With Congestive Heart Failure
5


















































































































































































































